{"blog": [], "keywords": [{"value": "Pershing Square Capital Management", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Ackman, William A", "name": "persons", "rank": "3", "is_major": "Y"}, {"value": "Hedge Funds", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Stocks and Bonds", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "6", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/03/16/business/dealbook/pressure-on-valeant-puts-william-ackmans-image-as-moneymaker-at-risk.html", "document_type": "article", "byline": {"person": [{"lastname": "STEVENSON", "firstname": "Alexandra", "role": "reported", "organization": "", "rank": 1}], "original": "By ALEXANDRA STEVENSON"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/03/16/business/16Ackman/16Ackman-thumbWide.jpg", "legacy": {"wide": "images/2016/03/16/business/16Ackman/16Ackman-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/03/16/business/16Ackman/16Ackman-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/16/business/16Ackman/16Ackman-articleLarge.jpg", "xlargeheight": "399", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 399}, {"url": "images/2016/03/16/business/16Ackman/16Ackman-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/16/business/16Ackman/16Ackman-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "943", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "Mr. Ackman of Pershing Square has stayed in the stock and sustained enormous losses on paper.", "pub_date": "2016-03-16T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Huge Pressure on Valeant Puts Ackman\u2019s Image as a Moneymaker at Risk", "main": "Pressure on Valeant Puts William Ackman\u2019s Image as Moneymaker at Risk"}, "print_page": "6", "snippet": "Mr. Ackman of Pershing Square has stayed in the stock and sustained enormous losses on paper.", "_id": "56e8a75b38f0d85c820e643d", "slideshow_credits": null, "abstract": "Pershing Square Capital Management has lost billions of dollars due to William A Ackman's bet on Valeant Pharmaceuticals International, which is putting pressure on Ackman and placing his reputation as bold moneymaker at risk."}